Developer docs
API playgroundTry for free, no card

Search company profiles

Streetlab

Full company profile

uuid00yp81t

Namestring
Streetlab
Legal namestring
Streetlab
Company typeenum
Private
Founded yearint
2011
Descriptiontext

Streetlab is a Paris-based privately held research and clinical services company founded in 2011 by ophthalmologist José-Alain Sahel, operating from the Institut de la Vision at the Centre Hospitalier National des Quinze-Vingts. The company provides VR-based functional vision assessment platforms — notably MOST-VR (mobility testing), VR-ViSA (visual search assessment), and SPOT — along with physical testing environments such as an artificial street, driving simulator, low vision room, and VR room. Its core technology uses virtual reality and simulated environments to deliver standardized, reproducible functional vision endpoints with precise experimental control (luminance, contrast) and automated scoring through a centralized Reading Center. The primary customers are pharmaceutical sponsors and Contract Research Organizations conducting regulated ophthalmology clinical trials in indications such as inherited retinal diseases, retinitis pigmentosa, glaucoma, and age-related macular degeneration, with secondary use cases in medical device validation (notably with Johnson & Johnson MedTech Vision) and rehabilitation research. Revenue is generated through direct enterprise sales of VR testing equipment and services, including on-site installation, staff certification, and ongoing quality control, with a recent strategic collaboration with OptymEdge (April 2026) aimed at integrating functional vision endpoints into global multi-site clinical studies.

Short descriptiontext

Streetlab is a Paris-based clinical research organization founded in 2011 that provides VR-based functional vision assessment platforms — MOST-VR and VR-ViSA — and rehabilitation services to pharmaceutical sponsors, CROs, and medical device companies conducting ophthalmology clinical trials for visually impaired patients.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersParis, France
HQ citystring
Paris
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
functional vision assessment, clinical trial endpoints, virtual reality ophthalmology, low vision rehabilitation, ophthalmology research services
NAICS code1 code
  • Medical and Diagnostic Laboratories6215
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Ophthalmology Clinical Trial Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1VR Testing Equipment and Services
TypeHardware Sales
Description

Streetlab provides VR-based testing solutions to clinical trial sponsors and clinical centers. Services include equipment installation, site certification, and centralized quality control through their Reading Center. The company appears to generate revenue through product deployment and testing services for pharmaceutical companies conducting clinical trials for ophthalmic treatments.

streetlab-vision.com
2Clinical Evaluation Services
TypeProfessional Services
Description

Co-design, evaluation, and rehabilitation services for assistive technologies and therapeutic solutions targeting visually impaired patients.

streetlab-vision.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 3 records shown
1VR-ViSA
Description

Virtual reality test measuring visual search capacity in patients with peripheral or central deficits, designed for clinical centers and laboratories.

streetlab-vision.com
+2 more records
Core offering1 text field

Streetlab develops and deploys Virtual Reality-based functional vision assessment tools (MOST-VR, VR-ViSA, SPOT) that pharmaceutical sponsors and CROs use as patient-relevant endpoints in regulated ophthalmology clinical trials. The company combines VR and physical testing environments with a centralized Reading Center for automated scoring and multisite quality control, and also delivers co-design, clinical evaluation, and rehabilitation services for assistive technologies targeting visually impaired patients.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • VR-ViSA discriminates disease stages from early to severe while control subjects remain stable
+3 more records
Product overview1 text field

Streetlab offers a platform of virtual reality-based functional vision assessment tools designed for clinical trials and therapeutic evaluation. The core products include MOST-VR for mobility testing and VR-ViSA for visual search assessment, both using immersive VR technology to measure patient performance in real-life inspired tasks. Additional offerings include evaluation services, rehabilitation support, and specialized testing platforms such as driving simulators and artificial street environments. The company positions its portfolio as enabling sponsors and CROs to incorporate patient-relevant functional vision measures alongside traditional endpoints in clinical studies.

Product and service6 records
1MOST-VR (MObility for STandardized Testing)
CategoryClinical trial functional vision assessment (mobility)
Description

Virtual reality mobility test designed for inherited retinal diseases that provides precise control of experimental conditions (luminance, contrast), strong correlation with physical mobility tests, automatic performance evaluation, and Reading Center quality control for multisite clinical trials. Intended for pharmaceutical sponsors and clinical centers assessing disease progression and therapeutic benefit.

2VR-ViSA (Visual Search Assessment)
CategoryClinical trial functional vision assessment (visual search)
Description

Immersive VR test measuring visual search capacity in patients with peripheral or central deficits using 20 natural scenes with controlled luminance and contrast, delivering immediate automated performance scores and centralized Reading Center verification. Designed for pharmaceutical sponsors and clinical centers requiring rapid, reliable, reproducible functional vision measures with minimal learning effects.

3SPOT
CategoryClinical trial functional vision assessment
Description

Functional vision assessment platform in the Streetlab product portfolio, listed under 'Produits' on the company site as part of its functional vision assessment offerings for clinical and research use.

4Co-design (Co-conception) services
CategoryResearch and consulting services for assistive technologies
Description

Professional service placing users (visually impaired patients) at the center of the design of new products and services, supporting developers of assistive devices and therapeutic solutions through user-centered co-design engagements.

5Evaluation services
CategoryClinical and product evaluation services
Description

Clinical and functional evaluation services that place visually impaired users at the center of evaluating new products, services, and therapeutic solutions, leveraging Streetlab's testing platforms and expertise in functional vision assessment.

6Rehabilitation (Réhabilitation) services
CategoryLow vision rehabilitation services
Description

Rehabilitation services aimed at restoring quality of life and independence in activities of daily living for visually impaired patients, using Streetlab's assessment platforms to inform tailored rehabilitation programs.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-04-28
Description

Strategic collaboration to expand the use of Virtual Reality for real-life functional vision assessments in regulated clinical trials. Combines OptymEdge's standardized visual function endpoints (including BCVA assessment, examiner training, and certification) with Streetlab's real-life functional vision and mobility testing. Aims to create scalable pathways for integrating functional vision endpoints into global clinical studies.

2Fondation Voir et Entendre (Institut de la Vision)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Co-founding partner. The company was created in 2011 by José-Alain Sahel as an association with the Foundation for Vision and Hearing (Institut de la Vision). Located at the heart of the Vision Institute.

streetlab-vision.com
3Université Pierre et Marie Curie
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Co-founding partner. University partner from the 2011 creation of Streetlab, providing academic and research collaboration.

streetlab-vision.com
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Co-founding partner. French federation of blind and visually impaired individuals, representing patient perspectives.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Co-founding partner. Additional institutional supporter from the 2011 creation of Streetlab.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Supporting partner. Provided support during the founding of Streetlab in 2011.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Long-standing collaboration with important milestones presented at ARVO conferences. Active partnership in vision research and development.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers7 records
TypeBroad incumbent
Description

Provider of clinical trial technology (eCOA, ePRO, rater training and endpoint solutions) to pharma/biotech sponsors. Comparable to Streetlab in delivering validated, centralized clinical trial endpoints and supporting global multisite trial execution, though across all therapeutic areas.

TypeBroad incumbent
Description

Specialty ophthalmology clinical research organization (CRO) running trials for pharma and device sponsors. Comparable because Ora and Streetlab both serve the same ophthalmology clinical trial sponsor market for endpoint development and trial execution, though Ora is broader and larger.

TypeDirect peer
Description

France-based developer of ophthalmology and neuro-ophthalmology diagnostic and assessment equipment, including visual function testing devices used in clinical research. Directly comparable to Streetlab's vision assessment hardware/software portfolio and its hospital-anchored research model.

TypeBroad incumbent
Description

Clinical trial endpoint technology and imaging provider offering centralized reading center and endpoint solutions to global sponsors. Comparable to Streetlab through its Reading Center-style centralized scoring services and endpoint play in regulated trials, though Clario operates across many therapeutic areas.

5Adaptive Sensory Technology
TypeEmerging player
Description

Developer of VR-based sensory and rehabilitation assessment tools (including for vestibular/balance and vision). Comparable to Streetlab's VR-based functional assessment approach in clinical and rehabilitation contexts, though focused on broader sensory/motor applications.

TypeEmerging player
Description

Clinical trial-focused computerized cognitive and neurological assessment provider serving pharma sponsors. Comparable to Streetlab as a validated cognitive/neurological endpoint play built around standardized, regulator-acceptable performance-based testing delivered into global trials.

TypeBroad incumbent
Description

eClinical platform provider (Rave, eCOA, sensor/endpoints) used in thousands of regulated trials. Comparable to Streetlab because Medidata provides the integrated endpoint infrastructure that sponsors use in ophthalmology trials, and could extend into functional vision endpoint capture.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Streetlab

Ophthalmology Clinical Trial Servicesstreetlab-vision.com

Streetlab is a Paris-based clinical research organization founded in 2011 that provides VR-based functional vision assessment platforms — MOST-VR and VR-ViSA — and rehabilitation services to pharmaceutical sponsors, CROs, and medical device companies conducting ophthalmology clinical trials for visually impaired patients.

What Streetlab does

Streetlab is a Paris-based privately held research and clinical services company founded in 2011 by ophthalmologist José-Alain Sahel, operating from the Institut de la Vision at the Centre Hospitalier National des Quinze-Vingts. The company provides VR-based functional vision assessment platforms — notably MOST-VR (mobility testing), VR-ViSA (visual search assessment), and SPOT — along with physical testing environments such as an artificial street, driving simulator, low vision room, and VR room. Its core technology uses virtual reality and simulated environments to deliver standardized, reproducible functional vision endpoints with precise experimental control (luminance, contrast) and automated scoring through a centralized Reading Center. The primary customers are pharmaceutical sponsors and Contract Research Organizations conducting regulated ophthalmology clinical trials in indications such as inherited retinal diseases, retinitis pigmentosa, glaucoma, and age-related macular degeneration, with secondary use cases in medical device validation (notably with Johnson & Johnson MedTech Vision) and rehabilitation research. Revenue is generated through direct enterprise sales of VR testing equipment and services, including on-site installation, staff certification, and ongoing quality control, with a recent strategic collaboration with OptymEdge (April 2026) aimed at integrating functional vision endpoints into global multi-site clinical studies.

Streetlab firmographics

Firmographics
Name
Streetlab
Legal name
Streetlab
Website
https://streetlab-vision.com
Company type
Private
Founded year
2011
Operating status
Operating
Headcount range
11–50 employees
Short description
Streetlab is a Paris-based clinical research organization founded in 2011 that provides VR-based functional vision assessment platforms — MOST-VR and VR-ViSA — and rehabilitation services to pharmaceutical sponsors, CROs, and medical device companies conducting ophthalmology clinical trials for visually impaired patients.
Ownership category
akta.pro rank

Where Streetlab is headquartered

Location

Headquarters

HQ city
Paris
HQ country
France
HQ region
Europe

Offices1 record

Markets served

Streetlab business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. VR Testing Equipment and Services: Streetlab provides VR-based testing solutions to clinical trial sponsors and clinical centers. Services include equipment installation, site certification, and centralized quality control through their Reading Center. The company appears to generate revenue through product deployment and testing services for pharmaceutical companies conducting clinical trials for ophthalmic treatments.
  2. Clinical Evaluation Services: Co-design, evaluation, and rehabilitation services for assistive technologies and therapeutic solutions targeting visually impaired patients.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Streetlab product offering

Product offering

Core offering

Streetlab develops and deploys Virtual Reality-based functional vision assessment tools (MOST-VR, VR-ViSA, SPOT) that pharmaceutical sponsors and CROs use as patient-relevant endpoints in regulated ophthalmology clinical trials. The company combines VR and physical testing environments with a centralized Reading Center for automated scoring and multisite quality control, and also delivers co-design, clinical evaluation, and rehabilitation services for assistive technologies targeting visually impaired patients.

Product overview

Streetlab offers a platform of virtual reality-based functional vision assessment tools designed for clinical trials and therapeutic evaluation. The core products include MOST-VR for mobility testing and VR-ViSA for visual search assessment, both using immersive VR technology to measure patient performance in real-life inspired tasks. Additional offerings include evaluation services, rehabilitation support, and specialized testing platforms such as driving simulators and artificial street environments. The company positions its portfolio as enabling sponsors and CROs to incorporate patient-relevant functional vision measures alongside traditional endpoints in clinical studies.

Differentiator

Problem solved

Functional benefit

Brands

  • VR-ViSA: Virtual reality test measuring visual search capacity in patients with peripheral or central deficits, designed for clinical centers and laboratories.
  • MOST-VR
  • SPOT

Products and services

  • MOST-VR (MObility for STandardized Testing) Virtual reality mobility test designed for inherited retinal diseases that provides precise control of experimental conditions (luminance, contrast), strong correlation with physical mobility tests, automatic performance evaluation, and Reading Center quality control for multisite clinical trials. Intended for pharmaceutical sponsors and clinical centers assessing disease progression and therapeutic benefit.
  • VR-ViSA (Visual Search Assessment) Immersive VR test measuring visual search capacity in patients with peripheral or central deficits using 20 natural scenes with controlled luminance and contrast, delivering immediate automated performance scores and centralized Reading Center verification. Designed for pharmaceutical sponsors and clinical centers requiring rapid, reliable, reproducible functional vision measures with minimal learning effects.
  • SPOT Functional vision assessment platform in the Streetlab product portfolio, listed under 'Produits' on the company site as part of its functional vision assessment offerings for clinical and research use.
  • Co-design (Co-conception) services Professional service placing users (visually impaired patients) at the center of the design of new products and services, supporting developers of assistive devices and therapeutic solutions through user-centered co-design engagements.
  • Evaluation services Clinical and functional evaluation services that place visually impaired users at the center of evaluating new products, services, and therapeutic solutions, leveraging Streetlab's testing platforms and expertise in functional vision assessment.
  • Rehabilitation (Réhabilitation) services Rehabilitation services aimed at restoring quality of life and independence in activities of daily living for visually impaired patients, using Streetlab's assessment platforms to inform tailored rehabilitation programs.

Quantifiable outcome

  • VR-ViSA discriminates disease stages from early to severe while control subjects remain stable
  • +3 more outcomes

Companies that use Streetlab

Customer profile

Named customers3 records

Segments4 records

Ideal customer profiles3 records

Streetlab technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature7 records

Streetlab partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered core and minor.

  • OptymEdgecoreStrategic or Co-development Partner · 28 April 2026Strategic collaboration to expand the use of Virtual Reality for real-life functional vision assessments in regulated clinical trials. Combines OptymEdge's standardized visual function endpoints (including BCVA assessment, examiner training, and certification) with Streetlab's real-life functional vision and mobility testing. Aims to create scalable pathways for integrating functional vision endpoints into global clinical studies.
  • Fondation Voir et Entendre (Institut de la Vision)coreStrategic or Co-development PartnerCo-founding partner. The company was created in 2011 by José-Alain Sahel as an association with the Foundation for Vision and Hearing (Institut de la Vision). Located at the heart of the Vision Institute.
  • Université Pierre et Marie CuriecoreStrategic or Co-development PartnerCo-founding partner. University partner from the 2011 creation of Streetlab, providing academic and research collaboration.
  • Fédération des Aveugles de FranceminorStrategic or Co-development PartnerCo-founding partner. French federation of blind and visually impaired individuals, representing patient perspectives.
  • USSIF (Institut de la Vision supporter)minorStrategic or Co-development PartnerCo-founding partner. Additional institutional supporter from the 2011 creation of Streetlab.
  • Ville de ParisminorStrategic or Co-development PartnerSupporting partner. Provided support during the founding of Streetlab in 2011.
  • Johnson & Johnson MedTech VisioncoreStrategic or Co-development PartnerLong-standing collaboration with important milestones presented at ARVO conferences. Active partnership in vision research and development.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Streetlab competitors and assessment

Company assessment

Broad incumbents

  • Signant Health: Provider of clinical trial technology (eCOA, ePRO, rater training and endpoint solutions) to pharma/biotech sponsors. Comparable to Streetlab in delivering validated, centralized clinical trial endpoints and supporting global multisite trial execution, though across all therapeutic areas.
  • Ora, Inc. Specialty ophthalmology clinical research organization (CRO) running trials for pharma and device sponsors. Comparable because Ora and Streetlab both serve the same ophthalmology clinical trial sponsor market for endpoint development and trial execution, though Ora is broader and larger.
  • Clario: Clinical trial endpoint technology and imaging provider offering centralized reading center and endpoint solutions to global sponsors. Comparable to Streetlab through its Reading Center-style centralized scoring services and endpoint play in regulated trials, though Clario operates across many therapeutic areas.
  • Medidata Solutions (Dassault Systèmes): eClinical platform provider (Rave, eCOA, sensor/endpoints) used in thousands of regulated trials. Comparable to Streetlab because Medidata provides the integrated endpoint infrastructure that sponsors use in ophthalmology trials, and could extend into functional vision endpoint capture.

Direct peers

  • Metrovision: France-based developer of ophthalmology and neuro-ophthalmology diagnostic and assessment equipment, including visual function testing devices used in clinical research. Directly comparable to Streetlab's vision assessment hardware/software portfolio and its hospital-anchored research model.

Emerging players

  • Adaptive Sensory Technology: Developer of VR-based sensory and rehabilitation assessment tools (including for vestibular/balance and vision). Comparable to Streetlab's VR-based functional assessment approach in clinical and rehabilitation contexts, though focused on broader sensory/motor applications.
  • Cogstate: Clinical trial-focused computerized cognitive and neurological assessment provider serving pharma sponsors. Comparable to Streetlab as a validated cognitive/neurological endpoint play built around standardized, regulator-acceptable performance-based testing delivered into global trials.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Streetlab social profiles

Digital presence

Streetlab financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Streetlab leadership team

Management profile

Number of profiles

Profiles1 record

Streetlab funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Streetlab M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Streetlab

What does Streetlab do?

Streetlab develops and deploys Virtual Reality-based functional vision assessment tools (MOST-VR, VR-ViSA, SPOT) that pharmaceutical sponsors and CROs use as patient-relevant endpoints in regulated ophthalmology clinical trials. The company combines VR and physical testing environments with a centralized Reading Center for automated scoring and multisite quality control, and also delivers co-design, clinical evaluation, and rehabilitation services for assistive technologies targeting visually impaired patients.

Is Streetlab a public or private company?

Streetlab is a private company. It is classified as unknown and is currently operating.

When was Streetlab founded?

Streetlab was founded in 2011. It employs 11 to 50 people.

Where is Streetlab based?

Streetlab is headquartered in Paris, France, in the Europe region.

How does Streetlab make money?

Two revenue lines are on record. VR Testing Equipment and Services are the primary driver. The others are clinical Evaluation Services.

Who are Streetlab's main competitors?

Broad incumbents on record are Signant Health, Ora, Inc., Clario and Medidata Solutions (Dassault Systèmes). Metrovision is listed as a direct peer. Emerging players are Adaptive Sensory Technology and Cogstate.

Does Streetlab have an API?

No public API is recorded for Streetlab.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals